The variable phenotypes of KCNQ-related epilepsy

Epilepsia

Volumn 55, Issue 9, 2014, Pages e99-e105

  Allen, Nicholas M ^a   Mannion, Maria ^a   Conroy, Judith ^b   Lynch, Sally A ^a,b   Shahwan, Amre ^a   Lynch, Bryan ^a   King, Mary D ^a,b  

^a CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Array CGH; CHRNA4; Encephalopathy; Epilepsy; KCNQ2; KCNQ3

Indexed keywords

POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KCNQ;

APNEA; ARTICLE; BASAL GANGLION; BENIGN CHILDHOOD EPILEPSY; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; CYANOSIS; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; GENE DELETION; GENE DUPLICATION; GENETIC TRAIT; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; INFANT; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; THALAMUS; TONIC CLONIC SEIZURE; ARRAY CGH; BRAIN DISEASE; CHRNA4; CHROMOSOME 22; CHROMOSOME DELETION; EPILEPSY; FEMALE; GENETIC ASSOCIATION; GENETICS; KCNQ2; KCNQ3; MALE; MUTATION; NEWBORN; PATHOLOGY;

ARRAY CGH; CHRNA4; ENCEPHALOPATHY; EPILEPSY; KCNQ2; KCNQ3;

BASAL GANGLIA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; INFANT, NEWBORN; KCNQ POTASSIUM CHANNELS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; PHENOTYPE; THALAMUS;

EID: 84908017826     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12715     Document Type: Article

References (24)

1. Zara F, Specchio N, Striano P, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia 2013;54:425-436.
2. Deprez L, Jansen A, De Jonghe P. Genetics of epilepsy syndromes starting in the first year of life. Neurology 2009;72:273-281.
3. Fister P, Soltirovska-Salamon A, Debeljak M, et al. Benign familial neonatal convulsions caused by mutation in KCNQ3, exon 6: a European case. Eur J Paediatr Neurol 2013;17:308-310.
4. Pascual KT, Wierenga KJ, Ng YT. Contiguous deletion of KCNQ2 and CHRNA4 may cause a different disorder from benign familial neonatal seizures. Epilepsy Behav Case Rep 2013;1:135-138.
5. Steinlein OK, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? Epilepsy Res 2007;73:245-249.
6. Dedek K, Fusco L, Teloy N, et al. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res 2003;54:21-27.
7. Weckhuysen S, Mandelstam S, Suls A, et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol 2012;71:15-25.
8. Weckhuysen S, Ivanovic V, Hendrickx R. KCNQ2 Study Group. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. Neurology 2013;81:1697-1703.
9. Kato M, Yamagata T, Kubota M, et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia 2013;54:1282-1287.
10. Milh M, Boutry-Kryza N, Sutera-Sardo J, et al. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. Orphanet J Rare Dis 2013;8:80.
11. Saitsu H, Kato M, Koide A, et al. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Ann Neurol 2012;72:298-300.
12. Numis AL, Angriman M, Sullivan JE, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014;2:368-370.
13. Orhan G, Bock M, Schepers D, et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. Ann Neurol 2014;75:382-394.
14. Volkers L, Rook MB, Das JH, et al. Functional analysis of novel KCNQ2 mutations found in patients with Benign Familial Neonatal Convulsions. Neurosci Lett 2009;462:24-29.
15. Li H, Li N, Shen L, et al. A novel mutation of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions. Epilepsy Res 2008;79:1-5.
16. Soldovieri MV, Boutry-Kryza N, Milh M, et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by Syntaxin- 1A. Hum Mutat 2014;35:356-367.
17. Kurahashi H, Wang JW, Ishii A, et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology 2009;73:1214-1217.
18. Béna F, Bottani A, Marcelli F, et al. A de novo 1.1-1.6 Mb subtelomeric deletion of chromosome 20q13.33 in a patient with learning difficulties but without obvious dysmorphic features. Am J Med Genet A 2007;143A:1894-1899.
19. Ardalan A, Prieur M, Choiset A, et al. Intrachromosomal insertion mimicking a pericentric inversion: molecular cytogenetic characterization of a three break rearrangement of chromosome 20. Am J Med Genet A 2005;138A:288-293.
20. Mefford HC, Cook J, Gospe SM Jr. Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy. Am J Med Genet A 2012;158A:3190-3195.
21. Traylor RN, Bruno DL, Burgess T, et al. A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33. PLoS ONE 2010;5:e12462.
22. Béri-Deixheimer M, Gregoire MJ, Toutain A, et al. Genotype- phenotype correlations to aid in the prognosis of individuals with uncommon 20q13.33 subtelomere deletions: a collaborative study on behalf of the 'association des Cytogénéticiens de langue Francáise'. Eur J Hum Genet 2007;15:446-452.
23. Millichap JJ, Cooper EC. KCNQ2 potassium channel epileptic encephalopathy syndrome: divorce of an electro-mechanical couple? Epilepsy Curr 2012;12:150-152.
24. Miceli F, Soldovieri MV, Ambrosino P, et al. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits. Proc Natl Acad Sci USA 2013;110:4386-4391.